MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/09546634.2018.1509049

Медицинская библиотека · The Journal of dermatological treatment · 2018

Comparing the short-term therapeutic effects and safety profiles of rituximab therapy in pemphigus vulgaris patients either early treated or later than six months.

Balighi Kamran, Daneshpazhooh Maryam, Akbari Zahra, Tavakolpour Soheil, Azimi Pourya, Azizpour Arghavan

Сравнительное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

Introduction

Rituximab is a recent treatment in recalcitrant pemphigus vulgaris (PV) patients. This study aims to establish the optimal time for rituximab therapy in PV patients.

Methods

In this retrospective study, patients who received rituximab within six months of diagnosis were classified as the early treatment group, and patients who have received it later than six months were classified as the delayed treatment group.

Results

Ninety-five PV patients were reviewed. Fourteen (14.8%) and 81 (85.2%) patients received rituximab within the first six-months from diagnosis and after that, respectively. In the former group, seven patients have received rituximab as the first-line therapy. The rate of complete remission off therapy (CR off therapy) was significantly higher in this early treatment group (92.9%) compared with the delayed treatment group (66.6%) (p = .47). The patients in early treated group significantly sooner achieved remission (p < .001) and it lasts for a longer time (p = .006). The relapse rate was also significantly lower in the early treatment group (five patients, 38.5%) compared with the delayed treatment group (54 patients, 71.1%) (p = .02).

Conclusions

Early treatment with rituximab can lead to a higher rate of complete remission, a lower rate of disease relapse, and longer duration of complete remission in PV patients.

Для цитирования: Balighi Kamran, Daneshpazhooh Maryam, Akbari Zahra, Tavakolpour Soheil, Azimi Pourya, Azizpour Arghavan. Comparing the short-term therapeutic effects and safety profiles of rituximab therapy in pemphigus vulgaris patients either early treated or later than six months.. The Journal of dermatological treatment. 2018. DOI: 10.1080/09546634.2018.1509049.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.